In a recent breakthrough, a study published in the Journal of the International Society of Sports Nutrition shines a light on the potential benefits of CBD, particularly touting its safety for everyday use. The controlled study, which gave subjects 100 mg of CBD daily for three months, found no adverse events in the healthy men and women participating, drawing parallel conclusions to prior animal studies on CBD’s well-tolerated nature.
An Insightful Conversation with Dr. Sibyl Swift of cbdMD
Speaking with experts at NutraIngredients-USA, Dr. Sibyl Swift from cbdMD elaborated on how the study’s results align with existing data and the clear tolerance of CBD from a scientific standpoint. The research, spearheaded by Dr. Shawn Arent at the University of South Carolina, divulged distinct physiological responses, with women experiencing notable improvements in pain scores and mood, while men saw decreases in inflammatory markers.
Rigorous evaluation over the 12-week period indicates promising health effects of hemp-derived CBD products in healthy adults—a pioneering feat in the realm of sports nutrition.
Challenges with Regulatory Acceptance
While cbdMD continues to back scientific research into CBD products, resistance from regulatory bodies, such as the U.S. Food and Drug Administration (FDA), remains a hurdle. Currently, the FDA does not recognize CBD as a legal dietary ingredient, citing concerns over its safety and the need for a new regulatory pathway.
Despite these regulatory challenges, Dr. Swift emphasizes the importance of continuing research in the realm of CBD and the palpable benefits, such as mood enhancement and pain management, supported by valid data. While the domestic environment might be unfavorable, Dr. Swift acknowledges thriving global opportunities, with active sales in Latin America and impending approval in the UK.
International Avenues for CBD Science
The lack of federal clarity on CBD in the U.S. has not stopped cbdMD from seeking out and succeeding in international markets, where scientific evidence is more warmly received. As many countries are more receptive to reviewing the safety and claims of CBD, international relief seems to be the current gateway for advancing CBD science and consumer benefits.
To delve deeper into the comprehensive results of this study and learn more about its implications on the health and wellness industry, view the full interview and obtain the study via open access below.
Study Source:
Journal of the High Quality Studies.
Published: Published online ahead of print. DOI: 10.1080/15502783.2024.2370430
Study Title: “The effects of a brand-specific, hemp-derived cannabidiol product on physiological, biochemical, and psychometric outcomes in healthy adults: a double-blind, randomized clinical trial”
Authors: G.F. Mastrofini et al.
Frequently Asked Questions (FAQs)
What is CBD?
CBD, or cannabidiol, is one of over a hundred compounds found in the Cannabis sativa plant known for its potential therapeutic effects without the psychoactive properties of THC, the compound associated with the “high” in marijuana.
Is CBD safe to consume?
According to recent studies, including the one cited in this article, CBD has been shown to be safe for consumption in healthy individuals when taken in appropriate doses.
How does the FDA currently regulate CBD?
The FDA does not currently approve CBD as a legal dietary ingredient, expressing the need for more research to establish its safety and efficacy.
Can CBD improve mood or aid in pain management?
Although not making direct disease claims, available research, including the study from the Journal of the International Society of Sports Nutrition, suggests that CBD may have positive effects on mood and may help with managing everyday aches and pains.
What are the legal implications of selling CBD products in the U.S.?
While many states have their own regulations permitting the sale of CBD, there is currently a lack of federal clarity on its status, making it a complex legal landscape for businesses to navigate.
0 Comments